Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats
- PMID: 15207546
- DOI: 10.1016/j.ejpb.2004.02.010
Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats
Abstract
The uptake of estradiol and progesterone into the cerebrospinal fluid (CSF) after intranasal and intravenous administration in rats was investigated. Each animal received estradiol intranasally (40 microg/rat) and by intravenous infusion (10 microg/rat) into the jugular vein using a vascular access port. Hereafter, the same set of rats was treated with progesterone intranasally (200 microg/rat) and by intravenous infusion (104 microg/rat). Following nasal delivery, both steroid hormones reach Cmax values in plasma and CSF at 15 min after administration. Intravenous infusion of estradiol and progesterone shows comparable plasma and CSF concentration-time profiles compared to the nasal route. For both hormones the AUCCSF/AUCplasma ratios (mean +/- SD) after intranasal delivery (estradiol 2.3 +/- 1.1%; progesterone 1.9 +/- 0.7%) do not differ significantly from the ratios shown after intravenous infusion (estradiol 2.0 +/- 0.6%; progesterone 2.2 +/- 0.8%). These results indicate that after nasal delivery estradiol and progesterone are rapidly absorbed into the systemic circulation, from where the non-protein bound hormones probably enter the CSF by crossing the blood-brain barrier. No extra direct nose-CSF transport could be demonstrated.
Copyright 2004 Elsevier B.V.
Similar articles
-
Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method.Int J Pharm. 2006 Jul 6;317(1):40-6. doi: 10.1016/j.ijpharm.2006.02.055. Epub 2006 Mar 12. Int J Pharm. 2006. PMID: 16631329
-
Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.Eur J Pharm Biopharm. 2008 Nov;70(3):735-40. doi: 10.1016/j.ejpb.2008.07.005. Epub 2008 Jul 18. Eur J Pharm Biopharm. 2008. PMID: 18684400
-
Uptake of fluorescein isothiocyanate-labelled dextran into the CSF after intranasal and intravenous administration to rats.Eur J Pharm Biopharm. 2005 Sep;61(1-2):27-31. doi: 10.1016/j.ejpb.2005.02.015. Eur J Pharm Biopharm. 2005. PMID: 15893918
-
Intranasal hormone replacement therapy.Menopause. 2003 Jan-Feb;10(1):88-98. doi: 10.1097/00042192-200310010-00014. Menopause. 2003. PMID: 12544682 Review.
-
Nanoparticles for direct nose-to-brain delivery of drugs.Int J Pharm. 2009 Sep 8;379(1):146-57. doi: 10.1016/j.ijpharm.2009.06.019. Epub 2009 Jun 23. Int J Pharm. 2009. PMID: 19555750 Review.
Cited by
-
Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders.Pharmaceutics. 2023 Dec 31;16(1):66. doi: 10.3390/pharmaceutics16010066. Pharmaceutics. 2023. PMID: 38258077 Free PMC article. Review.
-
Enhanced analgesic responses after preferential delivery of morphine and fentanyl to the olfactory epithelium in rats.Anesth Analg. 2011 Sep;113(3):641-51. doi: 10.1213/ANE.0b013e3182239b8c. Epub 2011 Jun 27. Anesth Analg. 2011. PMID: 21709146 Free PMC article.
-
Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies.Expert Opin Drug Deliv. 2018 Feb;15(2):163-172. doi: 10.1080/17425247.2018.1378642. Epub 2017 Sep 18. Expert Opin Drug Deliv. 2018. PMID: 28895435 Free PMC article. Review.
-
Laminar Fluid Ejection for Olfactory Drug Delivery: A Proof of Concept Study.IEEE J Transl Eng Health Med. 2024 Nov 20;12:727-738. doi: 10.1109/JTEHM.2024.3503498. eCollection 2024. IEEE J Transl Eng Health Med. 2024. PMID: 39698475 Free PMC article.
-
A Historical Review of Brain Drug Delivery.Pharmaceutics. 2022 Jun 16;14(6):1283. doi: 10.3390/pharmaceutics14061283. Pharmaceutics. 2022. PMID: 35745855 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources